Results 161 to 170 of about 298,611 (329)
Navigating challenges and opportunities in orphan medicines: A spotlight commentary on rare diseases
British Journal of Clinical Pharmacology, Volume 91, Issue 4, Page 1084-1087, April 2025.
Andrej Belančić +3 more
wiley +1 more source
British Journal of Clinical Pharmacology, EarlyView.Aims Amlodipine poisoning is a leading cause of cardiovascular medication‐related deaths, commonly managed with high‐dose insulin (HDI) therapy. However, HDI is a vasodilator that is counterproductive in managing vasoplegia. We aim to study HDI therapy in patients with hypotension following dihydropyridine calcium channel antagonist (CCA) overdose ...
Betty S. H. Chan +3 more
wiley +1 more source
Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde, 2019 Objetivo: Identificar as percepções dos farmacêuticos hospitalares enquanto às problemáticas e transformações que afetam a identidade como profissional da saúde.
GABRIEL BARRETO ROSSELLO
doaj
British Journal of Clinical Pharmacology, EarlyView.Aims To develop an evidence‐ and consensus‐based patient prioritization tool for use by UK mental health inpatient pharmacy teams. Methods A modified‐Delphi technique was used to obtain experts' agreement on the content, design and practical use of the patient prioritization tool.
Fatima Q. Alshaikhmubarak +3 more
wiley +1 more source
A pre- post-evaluation of implementing an inpatient warfarin monitoring and education program
Pharmacy Practice, 2011 Objective: The purpose of this study was to evaluate whether a new anticoagulation management program resulted in better monitoring of warfarin, increased warfarin patient education prior to discharge, and fewer bleeding complications associated with ...
Armstrong EP +3 more
doaj
British Journal of Clinical Pharmacology, EarlyView.Aims Amgevita is a licensed biosimilar to adalimumab, having demonstrated high pharmacokinetic and clinical similarity to Humira. Switching to a lower‐cost medicine may elicit a nocebo effect, whereby expectations of poorer efficacy impact outcomes despite pharmacological similarity. This prospective cohort study examined clinical and economic outcomes
Louise Rabbitt +7 more
wiley +1 more source
Epilepsia Open, EarlyView., 2022 Abstract Epilepsy syndromes during the early years of life may be attributed to an acquired insult, such as hypoxic–ischemic injury, infection, status epilepticus, or brain trauma. These conditions are frequently modeled in experimental rodents to delineate mechanisms of epileptogenesis and investigate novel therapeutic strategies.
Anna‐Maria Katsarou +7 more
wiley +1 more source
From hospital to community pharmacy – development of a pragmatic in-hospital service
, 2017 In Swiss ambulatory care, a patient’s medication is usually prescribed by the family general practitioner (GP) and dispensed by the community pharmacy. In the canton of Aargau (AG), GP and pharmacy density is lower than the Swiss average, and self-dispensing by physicians is not allowed.
openaire +3 more sources
British Journal of Clinical Pharmacology, EarlyView.Abstract Aims The perspectives of patients and healthcare professionals regarding deprescribing in surgical wards within hospital settings are unknown. The aim of this study was to explore current practices, attitudes and the enablers and barriers to deprescribing in hospital for older surgical inpatients from the perspectives of doctors, pharmacists ...
Bonnie M. Liu +5 more
wiley +1 more source
Epilepsia Open, EarlyView., 2022 Abstract Rodent models of epilepsy remain the cornerstone of research into the mechanisms underlying genetic epilepsy. Reproducibility of experiments using these rodent models, occurring across a diversity of laboratories and commercial vendors, remains an issue impacting the cost‐effectiveness and scientific rigor of the studies performed.
Massimo Mantegazza +7 more
wiley +1 more source